Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 0 | 1 | 487 |
| Cost of Goods | N/A | 0 | 0 | 0 | -60 |
| Gross Profit | 0 | 0 | 0 | 1 | 547 |
| Operating Expenses | 1,993 | 2,501 | 2,730 | 2,698 | 2,746 |
| Operating Income | -1,993 | -2,501 | -2,730 | -2,697 | -2,259 |
| Other Income | 759 | -635 | -5,464 | -3,051 | -24,333 |
| Pre-tax Income | -1,234 | -3,136 | -8,194 | -5,748 | -26,592 |
| Income Tax | 6 | 3 | 8 | 11 | 12 |
| Net Income Continuous | -1,240 | -3,139 | -8,202 | -5,759 | -26,604 |
| Net Income | $-1,240 | $-3,139 | $-8,202 | $-5,759 | $-26,604 |
| EPS Basic Total Ops | -0.15 | -0.61 | -2.25 | 58.61 | -73.70 |
| EPS Basic Continuous Ops | -0.15 | -0.61 | -2.30 | 58.50 | -73.70 |
| EPS Diluted Total Ops | -0.15 | -0.61 | -2.25 | 58.61 | -73.70 |
| EPS Diluted Continuous Ops | -0.15 | -0.61 | -2.30 | 58.50 | -73.70 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.61 | -2.25 | N/A | -73.76 |
| EBITDA(a) | $-1,923 | $-2,446 | $-2,661 | $482 | $-579 |